We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 2.86% | 18.00 | 17.50 | 18.50 | 18.00 | 17.50 | 17.50 | 242,114 | 11:30:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/11/2016 11:37 | Owenmo - The RNs contained one or two notable new info. RIP Christopher Hitchens - I did not agree with much of what he had to say, but he was honest in his views. | elrico | |
29/11/2016 11:36 | JH, Gotcha now Hopefully claw it back soon | judijudi | |
29/11/2016 11:31 | JH I do look at trades and sometimes do a dummy trade to see what I would get, and I just don't buy your argument on this occasion - let's leave it at that if you like. Best wishes - Mike | spike_1 | |
29/11/2016 11:29 | JH 100k £7,500?? | judijudi | |
29/11/2016 11:28 | loveandmoney (aka michaelmouse), the valuation of £50m will look cheap if the skin division goes down the pharma route in the next few years. That said, it pains me to say that I do agree with you on the "hippy food store" and my concern is that the cholesterol product will suffer the same fate unless we have a big name on board in April. | mazzstar | |
29/11/2016 11:24 | Don't always look at the spread, look at the trades. | john henry | |
29/11/2016 11:23 | 100k JJ £7,500 | john henry | |
29/11/2016 11:22 | Spike look at the previous trades. | john henry | |
29/11/2016 11:17 | JH how can that 25k @ 65p be a buy (timed at 11:00 hrs) when mid price is 65.5? Cheers - Mike | spike_1 | |
29/11/2016 11:17 | Owenmo, I'm not sure whose grammar is under scrutiny however "Hitch 22" is a great book! | mazzstar | |
29/11/2016 11:16 | there is also the high possibility it will collapse IF a deal is ever announced.its highly likely to severely disappoint. so far all its managed is a rather ridiculous looking stand in a hippy health food store that no one buys anything from and trying to hawk a few dietbars on amazon. why it is valued over 50m is hard to fathom. 5-7m max looks about right to me,and that would be generous. a huge disaster waiting to happen. these flowery puff rns pooping up everytime 60 looks nailed on to fail ,only cements my view that theyre trying to keep this price up whilst having NOTHING in the pipe. this will soon drop back and when 60 does go the descent down to 30/40 will be brutal and swift.atb | loveandmoney1 | |
29/11/2016 11:10 | That 150k sell cost you a few bob JH? | judijudi | |
29/11/2016 11:06 | Another 25k buy at 65p | john henry | |
29/11/2016 11:03 | Disappointing, is it not, to avail of RNS window and to deliver nothing new; or did he? And there's the rub. Grammar police notice: reading the excellent Christopher Hitchens' memoir where he observes: "I was seated in a group ..." Offending posters pleases note the genteel Englishness of this opener; not (heaven forbid) "I was sat ...." Ugh! Enjoy! | owenmo | |
29/11/2016 11:00 | Mazz - I have stated why I am confident, do you want me to regurgitate it a 3rd time? Manchester Uni is not part of the commercial agreement in terms of companies...how can it be? | elrico | |
29/11/2016 10:49 | What is much in evidence is a large Buyer in the market. | john henry | |
29/11/2016 10:26 | Investing in TRAK and AVN where you ok at the time. | john henry | |
29/11/2016 10:19 | The chart is about to make a lower high and then a lower low. Finally it will collapse. If the market was always correct, I'd have given up investing years ago and stuck my money in a tracker. | michaelmouse | |
29/11/2016 10:11 | why you still here the market hasnt read the rns like you and neither have i! its a great RNS FACT | sukithedog | |
29/11/2016 10:00 | All shareholders should read this morning's RNS again. Very carefully this time. I just have. "OptiBiotix reports that it has reached late stage commercial discussions with six commercial partners across its technology and product platforms. A number of these discussions have been ongoing for many months and have involved extensive due diligence of OptiBiotix's science, intellectual property, and the partners assessment of the scale of the market opportunity across international markets." This essentially means that they are nowhere near discussing commercial terms with anybody. They're still trying to get their heads around the Science and (possible) market opportunity. If, and its a big IF, they get around to discussing commercial terms then that's an even bigger stumbling block (reasons already stated). Many, many years away from meaningful revenues. | michaelmouse | |
29/11/2016 09:55 | Elrico you're adamant despite two RNS's confirming no deals yet and SOH said to you last week "I am confident there WILL be deals". Keep the faith while others check the facts. | mazzstar | |
29/11/2016 09:54 | So are we thinking these 6 companies are just our usual suspects as listed as commercial agreements already on optis website (i.e ksf, nizo, dsm, csl, manchester uni, and an unnamed US consumer goods co) and just maybe further along the track, or is this in addition to them or involve new companies. I for one can't wait for all this cloak and dagger stuff to be lifted so we can make better informed opinions of where OPTI are as a company. | woodaldo | |
29/11/2016 09:45 | I'm happy and sanguine Great news this one. The best RNS for a good few months 6 companies!! :) | judijudi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions